Guo Tong Xu
Director/Board Member chez ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Profil
Guo Tong Xu is currently an independent director at Zhejiang Shapuaisi Pharmaceutical Co. Ltd., Guangzheng Eye Hospital Group Co., Ltd., PharmaLegacy Laboratories (Shanghai) Co., Ltd., and Gracell Biotechnologies, Inc. He is also a professor at Tongji University.
Previously, he served as an independent director at AbelZeta Pharma, Inc. and as the Director-Stem Cell Bank at Temple University School of Medicine.
Dr. Xu received his undergraduate degree from Harbin Medical University and his doctorate from the University of North Texas Health Science Center, Chinese Academy of Medical Sciences, and Peking Union Medical College.
Postes actifs de Guo Tong Xu
| Sociétés | Poste | Début |
|---|---|---|
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Director/Board Member | 28/08/2020 |
| GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Director/Board Member | 01/06/2018 |
| GRACELL BIOTECHNOLOGIES INC. | Director/Board Member | 01/02/2019 |
| Tongji University | Corporate Officer/Principal | 01/01/2008 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 01/07/2022 |
Anciens postes connus de Guo Tong Xu
| Sociétés | Poste | Fin |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Director/Board Member | 11/11/2016 |
| Temple University School of Medicine | Corporate Officer/Principal | 01/07/2016 |
Formation de Guo Tong Xu
| Harbin Medical University | Undergraduate Degree |
| University of North Texas Health Science Center | Doctorate Degree |
| Chinese Academy of Medical Sciences | Doctorate Degree |
| Peking Union Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
| GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Health Services |
| Entreprise privées | 3 |
|---|---|
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
